Table 1. Correlation between GAS5-AS1 expression and clinicopathological parameters of NSCLC patients.
Characteristics | N of cases | Relative expression of GAS5-AS1 |
||
---|---|---|---|---|
Low | High | P-valuea | ||
Age (years) | 0.53 | |||
≤65 | 31 | 26 | 5 | |
>65 | 17 | 13 | 4 | |
Gender | 0.218 | |||
male | 36 | 30 | 6 | |
female | 12 | 8 | 4 | |
Differentiation | 0.485 | |||
well, moderate | 27 | 21 | 6 | |
poor | 21 | 18 | 3 | |
Tumor size (maximum diameter) | 0.019* | |||
≤3 cm | 16 | 10 | 6 | |
>3 cm | 32 | 29 | 3 | |
Smoking History | 0.565 | |||
smokers | 28 | 22 | 6 | |
never Smokers | 20 | 15 | 6 | |
Histology type | 0.39 | |||
adenocarcinoma | 23 | 17 | 6 | |
squamous carcinoma | 25 | 21 | 4 | |
Lymph node metastasis | 0.022* | |||
positive | 27 | 25 | 2 | |
negative | 21 | 14 | 7 | |
TMN stage | 0.017* | |||
I | 18 | 11 | 7 | |
II/III/IV | 30 | 27 | 3 |
aChi-square test.
*P < 0.05.